Skip to main content
SpringerLink
Log in

Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2

  • Original Research
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Carvacrol is one of the members of monoterpene phenol and is present in the volatile oils of Thymus vulgaris, Carum copticum, origanum and oregano. It is a safe food additive commonly used in our daily life, and few studies have indicated that carvacrol has anti-hepatocarcinogenic activities. The rationale of the study was to examine whether carvacrol affects apoptosis of human hepatoma HepG2 cells. In this study, we showed that carvacrol inhibited HepG2 cell growth by inducing apoptosis as evidenced by Hoechst 33258 stain and Flow cytometric (FCM) analysis. Incubation of HepG2 cells with carvacrol for 24 h induced apoptosis by the activation of caspase-3, cleavage of PARP and decreased Bcl-2 gene expression. These results demonstrated that a significant fraction of carvacrol treated cells died by an apoptotic pathway in HepG2 cells. Moreover, carvacrol selectively altered the phosphorylation state of members of the MAPK superfamily, decreasing phosphorylation of ERK1/2 significantly in a dose-dependent manner, and activated phosphorylation of p38 but not affecting JNK MAPK phosphorylation. These results suggest that carvacrol may induce apoptosis by direct activation of the mitochondrial pathway, and the mitogen-activated protein kinase pathway may play an important role in the antitumor effect of carvacrol. These results have identified, for the first time, the biological activity of carvacrol in HepG2 cells and should lead to further development of carvacrol for liver disease therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Aligiannis N, Kalpoutzakis E, Mitaku S, Chinou IB (2001) Composition and antimicrobial activity of the essential oils of two Origanum species. J Agric Food Chem 49:4168–4170

    Article  CAS  Google Scholar 

  • Arunasree K (2010) Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 17:581–588

    Article  CAS  Google Scholar 

  • Binetruy B, Heasley L, Bost F, Caron L, Aouadi M (2007) Concise review: regulation of embryonic stem cell lineage commitment by mitogen activated protein kinases. Stem Cells 25:1090–1095

    Article  CAS  Google Scholar 

  • Can Baser K (2008) Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 14:3106–3119

    Article  Google Scholar 

  • Chan ASL, Pang H, Yip ECH, Tam YK, Wong YH (2005) Carvacrol and eugenol differentially stimulate intracellular Ca2+ mobilization and mitogen-activated protein kinases in jurkat T-Cells and monocytic THP-1 Cells. Planta Med 71:634–639

    Article  CAS  Google Scholar 

  • Chang HL, Wu YC, Su JH, Yeh YT, Yuan SSF (2008) Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. J Pharmacol Exp Ther 325:841–849

    Article  CAS  Google Scholar 

  • Douer D, Tallman MS (2005) Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 23:2396–2410

    Article  CAS  Google Scholar 

  • Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43–50

    Article  CAS  Google Scholar 

  • Gopalakrishnan A, Xu CJ, Nair SS, Chen C, Hebbar V, Kong ANT (2006) Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells. Arch Pharm Res 29:633–644

    Article  CAS  Google Scholar 

  • Hagemann C, Blank JL (2001) The ups and downs of MEK kinase interactions. Cell Signal 13:863–875

    Article  CAS  Google Scholar 

  • He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE (1997) Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127:668–674

    CAS  Google Scholar 

  • Horvathova E, Turcaniova V, Slamenova D (2007) Comparative study of DNA-damaging and DNA-protective effects of selected components of essential plant oils in human leukemic cells K562. Neoplasma 54:478–483

    CAS  Google Scholar 

  • Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619–4628

    Article  CAS  Google Scholar 

  • Ipek E, Tuylu BA, Zeytinoglu H (2003) Effects of carvacrol on sister chromatid exchanges in human lymphocyte cultures. Cytotechnology 43:145–148

    Article  Google Scholar 

  • Junttila MR, Li SP, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22:954–965

    Article  CAS  Google Scholar 

  • Karkabounas S, Kostoula O, Daskalou T, Veltsistas P, Karamouzis M, Zelovitis I, Metsios A, Lekkas P, Evangelou A, Kotsis N (2006) Anticarcinogenic and antiplatelet effects of carvacrol. Exp Oncol 28:121–125

    CAS  Google Scholar 

  • Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ (2004) Natural inhibitors of carcinogenesis. Planta Med 70:691–705

    Article  CAS  Google Scholar 

  • Kisk G, Roller S (2005) Carvacrol and p-cymene inactivate Escherichia coli O157: H7 in apple juice. BMC Microbiol 5:36

    Article  Google Scholar 

  • Koparal AT, Zeytinoglu M (2003) Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549. Cytotechnology 43:149–154

    Article  Google Scholar 

  • Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52

    Article  Google Scholar 

  • Lampronti I, Saab AM, Gambari R (2006) Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. Int J Oncol 29:989–995

    CAS  Google Scholar 

  • Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF, Tseng TH (2005) Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol 203:124–131

    Article  CAS  Google Scholar 

  • Lee J, Jung E, Yu H, Kim Y, Ha J, Kim YS, Park D (2008) Mechanisms of carvacrol-induced expression of type I collagen gene. J Dermatol Sci 52:160–169

    Article  CAS  Google Scholar 

  • Martins RRL, Neves MG, Silvestre AJD, Silva A, Cavaleiro JAS (1999) Oxidation of aromatic monoterpenes with hydrogen peroxide catalysed by Mn(III) porphyrin complexes. J Mol Catal A: Chem 137:41–47

    Article  CAS  Google Scholar 

  • McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19:3–23

    Article  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  Google Scholar 

  • Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–183

    Article  CAS  Google Scholar 

  • Sarkar FH, Li Y (2004) Cell signaling pathways altered by natural chemopreventive agents. Mutat Res/Fundam Mol Mech Mutagen 555:53–64

    Article  CAS  Google Scholar 

  • Simstein R, Burow M, Parker A, Weldon C, Beckman B (2003) Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med 228:995–1003

    CAS  Google Scholar 

  • Sokmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, Tepe B, Akpulat HA, Sahin F, Sokmen A (2004) In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens. J Agric Food Chem 52:3309–3312

    Article  Google Scholar 

  • Stammati A, Bonsi P, Zucco F, Moezelaar R, Alakomi HL, Von Wright A (1999) Toxicity of selected plant volatiles in microbial and mammalian short-term assays. Food Chem Toxicol 37:813–823

    Article  CAS  Google Scholar 

  • Surh YJ (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res/Fundam Mol Mech Mutag 428:305–327

    Article  CAS  Google Scholar 

  • Wolf B, Brischwein M, Lob V, Ressler J, Wiest J (2007) Cellular signaling: aspects for tumor diagnosis and therapy. Biomedizinische Technik 52:164–168

    Article  Google Scholar 

  • Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331

    Article  CAS  Google Scholar 

  • Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44

    Article  CAS  Google Scholar 

  • Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J (2004) Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10:2024–2028

    CAS  Google Scholar 

  • Zeytinoglu M, Aydin S, Ztrk Y, Hsn K, Baser C (1998) Inhibitory effects of carvacrol on DMBA induced pulmonary tumorigenesis in rats. Acta Pharmaceutica Turcica 40:93–98

    CAS  Google Scholar 

  • Zeytinoglu H, Incesu Z, Baser K (2003) Inhibition of DNA synthesis by Carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. Phytomedicine 10:292–299

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, The First Affiliated Hospital of University of South China, Hengyang, 421001, People’s Republic of China

    Qing-hua Yin, You-hua Wu, Xiao-ping Wu, Ming-chu Liao, Shu-wen Deng, Lei-lan Yin & Ying-zhi Zhuang

  2. Institutes of Pharmacy and Pharmacology, University of South China, Hengyang, 421001, People’s Republic of China

    Feng-xiang Yan

  3. Institutes of Clinical Research, The First Affiliated Hospital of University of South China, Hengyang, 421001, People’s Republic of China

    Xu-Yu Zu

Authors
  1. Qing-hua Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feng-xiang Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xu-Yu Zu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. You-hua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiao-ping Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ming-chu Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shu-wen Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lei-lan Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ying-zhi Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ying-zhi Zhuang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yin, Qh., Yan, Fx., Zu, XY. et al. Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 64, 43–51 (2012). https://doi.org/10.1007/s10616-011-9389-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-011-9389-y

Keywords

Search

Navigation